What happened, in summary

Shyreece’s fourth video focuses on the lessons she learned as a Black woman living with Stage IV lung cancer and on the advocacy that grew from her experience. She described a frightening beginning: within about 2 weeks, she went from symptoms and hospital evaluation to a Stage IV lung cancer diagnosis. At first, she did not know about biomarkers or ALK-positive lung cancer. Doctors started an intensive chemotherapy approach that she remembered as a 4- to 5-hour infusion including “Carbo.” On April 18, 2014, a CT scan showed no evidence of disease. Later, after moving care across major centers, a PET scan at Stanford found 4 to 5 small brain tumors that had not been seen on CT scans. Over time, biomarker testing and education helped her understand that her cancer was ALK-rearranged / ALK-positive, opening different treatment options than the generic picture of lung cancer she had previously known. The current drug names and trial options in this video are not clear enough to list. As of March 2022, Shyreece was approaching major long-term scan milestones while still facing treatment decisions. She used her story to push for better outreach, biomarker testing, clinical-trial access, and more Black representation in research and lung cancer care.